Login to myESAIC Membership


The ESAIC is dedicated to supporting professionals in anaesthesiology and intensive care by serving as the hub for development and dissemination of valuable educational, scientific, research, and networking resources.



The ESAIC hosts the Euroanaesthesia and Focus Meeting congresses that serve as platforms for cutting-edge science and innovation in the field. These events bring together experts, foster networking, and facilitate knowledge exchange in anaesthesiology, intensive care, pain management, and perioperative medicine. Euroanaesthesia is one of the world’s largest and most influential scientific congresses for anaesthesia professionals. Held annually throughout Europe, our congress is a contemporary event geared towards education, knowledge exchange and innovation in anaesthesia, intensive care, pain and perioperative medicine, as well as a platform for immense international visibility for scientific research.


Professional Growth

The ESAIC's mission is to foster and provide exceptional training and educational opportunities. The ESAIC ensures the provision of robust and standardised examination and certification systems to support the professional development of anaesthesiologists and to ensure outstanding future doctors in the field of anaesthesiology and intensive care.



The ESAIC aims to advance patient outcomes and contribute to the progress of anaesthesiology and intensive care evidence-based practice through research. The ESAIC Clinical Trial Network (CTN), the Academic Contract Research Organisation (A-CRO), the Research Groups and Grants all contribute to the knowledge and clinical advances in the peri-operative setting.

Learn more about the ESAIC Clinical Trial Network (CTN) and the associated studies.


EU Projects

The ESAIC is actively involved as a consortium member in numerous EU funded projects. Together with healthcare leaders and practitioners, the ESAIC's involvement as an EU project partner is another way that it is improving patient outcomes and ensuring the best care for every patient.


Patient Safety

The ESAIC aims to promote the professional role of anaesthesiologists and intensive care physicians and enhance perioperative patient outcomes by focusing on quality of care and patient safety strategies. The Society is committed to implementing the Helsinki Declaration and leading patient safety projects.



To ESAIC is committed to implementing the Glasgow Declaration and drive initiatives towards greater environmental sustainability across anaesthesiology and intensive care in Europe.



The ESAIC works in collaboration with industry, national societies, and specialist societies to promote advancements in anaesthesia and intensive care. The Industry Partnership offers visibility and engagement opportunities for industry participants with ESAIC members, facilitating understanding of specific needs in anaesthesiology and in intensive care. This partnership provides resources for education and avenues for collaborative projects enhancing science, education, and patient safety. The Specialist Societies contribute to high-quality educational opportunities for European anaesthesiologists and intensivists, fostering discussion and sharing, while the National Societies, through NASC, maintain standards, promote events and courses, and facilitate connections. All partnerships collectively drive dialogue, learning, and growth in the anaesthesiology and intensive care sector.



Guidelines play a crucial role in delivering evidence-based recommendations to healthcare professionals. Within the fields of anaesthesia and intensive care, guidelines are instrumental in standardizing clinical practices and enhancing patient outcomes. For many years, the ESAIC has served as a pivotal platform for facilitating continuous advancements, improving care standards and harmonising clinical management practices across Europe.



With over 40 years of publication history, the EJA (European Journal of Anaesthesiology) has established itself as a highly respected and influential journal in its field. It covers a wide range of topics related to anaesthesiology and intensive care medicine, including perioperative medicine, pain management, critical care, resuscitation, and patient safety.



Becoming a member of ESAIC implies becoming a part of a vibrant community of nearly 8,000 professionals who exchange best practices and stay updated on the latest developments in anaesthesiology, intensive care and perioperative medicine. ESAIC membership equips you with the tools and resources necessary to enhance your daily professional routine, nurture your career growth, and play an active role in advancing anaesthesiology, intensive care and perioperative medicine.

Membership opportunities
at the ESAIC

Congress Newsletter 2021

EA21 Newsletter: Muscles seem to grow, rather than shrink, in some critically ill Covid patients

Muscles appear to grow, rather than shrink, in some critically ill COVID-19 patients, finds new research being presented in an abstract at this year’s Euroanaesthesia.

Bed rest and mechanical ventilation can lead to muscle wastage, which can hamper recovery and affect mobility and quality of life. Previous research has shown that muscle fibres atrophy by almost 20% after a week in ICU. There are concerns, however, that Covid may lead to even greater muscle damage.

To find out more, Dr Toon Mostien and colleagues at the Jessa Hospital, Hasselt, and Hasselt University, Belgium took muscle biopsies from critically ill Covid patients before and after intensive care admission.

Eighteen patients had their vastus lateralis, the largest and most powerful muscle in the thigh, biopsied multiple times from 1-3 days before ICU admission to 5-8 days after admission.

The patients had an average age of 69 years and 82% were male.

The samples were examined under the microscope for any changes that had occurred during the first week in ICU.

Type I muscle fibres (which support endurance activities) grew by 5.74% and type 2 fibres (which support quick, powerful moments) shrank by 5.17% but the changes weren’t statistically significant.

To the researchers’ surprise, the muscle fibres of four patients, however, increased “massively” in size. Type I fibres had swollen by 62% and type II fibres by 32%.

However, if these patients were excluded from the calculations, the remaining patients showed significant muscle wastage, says Dr Mostien. Type I fibres shrank by 11% and type 2 fibres by 17%.

It isn’t known why the muscle fibres increased in size in four of the patients but one possibility is that their immune response to Covid damaged their mitochondria, the tiny structures that provide cells with energy.

This drop in energy could lead to more water accumulating inside the muscle cells, causing them to swell.

This type of swelling can lead to muscle fibres dying and so it is likely the increase in muscle fibre size was only temporary, says Dr Mostien.

The researchers also examined the number of capillary contacts – the number of capillaries perfusing the muscle fibres with the oxygen and nutrients they need to thrive.

This decreased by 5.37% and 9.68% for type I and type II muscle fibres, respectively. Dr Mostien says: “Although the results were not significant, a drop in perfusion of almost 10% could potentially contribute to muscle fibre destruction.”

Dr Mostien concludes: “There are concerns that immune response to Covid can exacerbate muscle wastage, meaning that critically ill Covid patients experience more severe muscle damage than the general ICU population.

“Given the global burden of COVID-19, it is vital we learn more about this and our research is an important first step.”

Author Dr Toon Mostien, Jessa Hospital, Hasselt, Belgium can be contacted on: E) tmostien@gmail.com

For the full abstract click here

For the full poster click here

Read More of our special newsletter covering our virtual congress